Orthofix Reports First Quarter 2026 Results Highlighting Steady Execution Following Spine Commercial Channel Actions; Reaffirms Full-Year 2026 Financial Guidance

About this update from Orthofix Medical Inc.

[{"type":"image","alt":"","displaySize":"","headline":null,"caption":"","credit":null,"className":"","disableSlideshowImg":false,"size":{"original":{"width":1528,"height":235,"url":"https://media.zenfs.com/en/business-wire.com/f9e002724fb76b5181072d4b40f4fa9d"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/3sHt5gl5yCcX.0Xf5xo3mA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTE0OA--/https://media.zenfs.com/en/business-wire.com/f9e002724fb76b5181072d4b40f4fa9d","width":960,"height":148},"lightbox":{"url":"https://s.yimg.com/ny/api/res/1.2/SJMwMv4yidI9.HcKvuff5A--/YXBwaWQ9aGlnaGxhbmRlcjt3PTI0MDA7aD0zNzA-/https://media.zenfs.com/en/business-wire.com/f9e002724fb76b5181072d4b40f4fa9d","width":1200,"height":185}},"lazy":false},{"type":"text","content":" ","length":6,"tagName":"p","attribs":{}},{"type":"text","content":"LEWISVILLE, Texas, May 05, 2026--(BUSINESS WIRE)--Orthofix Medical Inc. (NASDAQ:OFIX), a leading global medical technology company, today reported its financial results for the first quarter ended March 31, 2026, reflecting steady execution following recent spine commercial channel actions. Based on first-quarter performance, the Company reaffirmed its full-year 2026 financial guidance. All pro forma measures contained within this release exclude the impact of the Company’s decision to discontinue its M6™ product lines.","length":525,"tagName":"p"},{"type":"text","content":"Highlights","length":10,"tagName":"p"},{"type":"list","items":[{"val":[{"type":"text","content":"First quarter 2026 reported net sales of $196.7 million, including sales from M6 artificial cervical and lumbar discs. Non-GAAP pro forma net sales of $196.4 million, excluding sales from M6 discs, increased 3% year over year on a constant currency basis, reflecting steady execution during the final stages of distributor transitions, with further improvement expected as productivity increases.","length":396,"tagName":"p","attribs":{}}]},{"val":[{"type":"text","content":"Global Spine Fixation1 delivered reported net sales growth of 6% and constant currency growth of 6% compared to the prior year period, including U.S. Spine Fixation growth of 4%, driven by enhanced commercial focus, deeper procedural penetration, and continuing benefits from distributor transition initiatives.","length":311,"tagName":"p","attribs":{}}]},{"val":[{"type":"text","content":"Therapeutic Solutions (formerl...

More updates from Orthofix Medical Inc.